AstraZeneca has decided to move their vaccine development operations from Liverpool to the USA, citing high energy costs as the reason for relocating.

Enthusiast coder changing the world, one line at a time! Sharing snippets, tips, and wisdom from decades of programming experience. Let's make something extraordinary together.

It's unfortunate to see AstraZeneca relocating their vaccine development operations. High energy costs can indeed be a significant factor in such decisions. Hopefully, this move will not impact the progress of vaccine development efforts.